nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—ATP4A—larynx—muscle cancer	0.0661	0.683	CbGeAlD
Esomeprazole—ATP4A—renal system—muscle cancer	0.0111	0.114	CbGeAlD
Esomeprazole—ATP4A—head—muscle cancer	0.0074	0.0765	CbGeAlD
Esomeprazole—ATP4A—testis—muscle cancer	0.00715	0.0739	CbGeAlD
Esomeprazole—CYP2C19—vagina—muscle cancer	0.0028	0.0289	CbGeAlD
Esomeprazole—CYP3A4—renal system—muscle cancer	0.00228	0.0236	CbGeAlD
Esomeprazole—Asthma—Methotrexate—muscle cancer	0.00142	0.00157	CcSEcCtD
Esomeprazole—Chest pain—Etoposide—muscle cancer	0.0014	0.00155	CcSEcCtD
Esomeprazole—Migraine—Doxorubicin—muscle cancer	0.0014	0.00155	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00139	0.00154	CcSEcCtD
Esomeprazole—Pancreatitis—Methotrexate—muscle cancer	0.00139	0.00154	CcSEcCtD
Esomeprazole—Discomfort—Etoposide—muscle cancer	0.00139	0.00153	CcSEcCtD
Esomeprazole—Face oedema—Doxorubicin—muscle cancer	0.00137	0.00152	CcSEcCtD
Esomeprazole—Hypersensitivity—Dactinomycin—muscle cancer	0.00137	0.00152	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Vincristine—muscle cancer	0.00136	0.0015	CcSEcCtD
Esomeprazole—Confusional state—Etoposide—muscle cancer	0.00136	0.0015	CcSEcCtD
Esomeprazole—Pancytopenia—Methotrexate—muscle cancer	0.00134	0.00149	CcSEcCtD
Esomeprazole—Anaphylactic shock—Etoposide—muscle cancer	0.00134	0.00149	CcSEcCtD
Esomeprazole—Infection—Etoposide—muscle cancer	0.00134	0.00148	CcSEcCtD
Esomeprazole—Asthenia—Dactinomycin—muscle cancer	0.00133	0.00148	CcSEcCtD
Esomeprazole—Blood creatinine increased—Doxorubicin—muscle cancer	0.00133	0.00147	CcSEcCtD
Esomeprazole—Neutropenia—Methotrexate—muscle cancer	0.00132	0.00147	CcSEcCtD
Esomeprazole—Dysuria—Methotrexate—muscle cancer	0.00132	0.00147	CcSEcCtD
Esomeprazole—Thrombocytopenia—Etoposide—muscle cancer	0.00132	0.00146	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00132	0.00146	CcSEcCtD
Esomeprazole—Tachycardia—Etoposide—muscle cancer	0.00131	0.00145	CcSEcCtD
Esomeprazole—Abdominal pain—Vincristine—muscle cancer	0.00131	0.00145	CcSEcCtD
Esomeprazole—Body temperature increased—Vincristine—muscle cancer	0.00131	0.00145	CcSEcCtD
Esomeprazole—Skin disorder—Etoposide—muscle cancer	0.00131	0.00145	CcSEcCtD
Esomeprazole—Erectile dysfunction—Methotrexate—muscle cancer	0.0013	0.00144	CcSEcCtD
Esomeprazole—Dry skin—Doxorubicin—muscle cancer	0.0013	0.00144	CcSEcCtD
Esomeprazole—Hyperhidrosis—Etoposide—muscle cancer	0.0013	0.00144	CcSEcCtD
Esomeprazole—Abdominal pain upper—Doxorubicin—muscle cancer	0.0013	0.00143	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Methotrexate—muscle cancer	0.00129	0.00143	CcSEcCtD
Esomeprazole—Hypokalaemia—Doxorubicin—muscle cancer	0.00129	0.00143	CcSEcCtD
Esomeprazole—Breast disorder—Doxorubicin—muscle cancer	0.00128	0.00142	CcSEcCtD
Esomeprazole—Anorexia—Etoposide—muscle cancer	0.00128	0.00142	CcSEcCtD
Esomeprazole—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00128	0.00141	CcSEcCtD
Esomeprazole—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00128	0.00141	CcSEcCtD
Esomeprazole—Diarrhoea—Dactinomycin—muscle cancer	0.00127	0.00141	CcSEcCtD
Esomeprazole—Infestation NOS—Methotrexate—muscle cancer	0.00126	0.0014	CcSEcCtD
Esomeprazole—Infestation—Methotrexate—muscle cancer	0.00126	0.0014	CcSEcCtD
Esomeprazole—Depression—Methotrexate—muscle cancer	0.00126	0.00139	CcSEcCtD
Esomeprazole—Gastritis—Doxorubicin—muscle cancer	0.00126	0.00139	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00125	0.00139	CcSEcCtD
Esomeprazole—Muscular weakness—Doxorubicin—muscle cancer	0.00125	0.00139	CcSEcCtD
Esomeprazole—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00125	0.00139	CcSEcCtD
Esomeprazole—Renal failure—Methotrexate—muscle cancer	0.00124	0.00137	CcSEcCtD
Esomeprazole—Abdominal distension—Doxorubicin—muscle cancer	0.00123	0.00137	CcSEcCtD
Esomeprazole—Stomatitis—Methotrexate—muscle cancer	0.00123	0.00136	CcSEcCtD
Esomeprazole—Conjunctivitis—Methotrexate—muscle cancer	0.00123	0.00136	CcSEcCtD
Esomeprazole—Asthma—Doxorubicin—muscle cancer	0.00123	0.00136	CcSEcCtD
Esomeprazole—Influenza—Doxorubicin—muscle cancer	0.00123	0.00136	CcSEcCtD
Esomeprazole—Dysphagia—Doxorubicin—muscle cancer	0.00123	0.00136	CcSEcCtD
Esomeprazole—Hypersensitivity—Vincristine—muscle cancer	0.00122	0.00135	CcSEcCtD
Esomeprazole—Paraesthesia—Etoposide—muscle cancer	0.00121	0.00134	CcSEcCtD
Esomeprazole—Haematuria—Methotrexate—muscle cancer	0.0012	0.00133	CcSEcCtD
Esomeprazole—Pancreatitis—Doxorubicin—muscle cancer	0.0012	0.00133	CcSEcCtD
Esomeprazole—Dyspnoea—Etoposide—muscle cancer	0.0012	0.00133	CcSEcCtD
Esomeprazole—Somnolence—Etoposide—muscle cancer	0.0012	0.00132	CcSEcCtD
Esomeprazole—Angina pectoris—Doxorubicin—muscle cancer	0.00119	0.00132	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Methotrexate—muscle cancer	0.00119	0.00132	CcSEcCtD
Esomeprazole—Epistaxis—Methotrexate—muscle cancer	0.00119	0.00132	CcSEcCtD
Esomeprazole—Asthenia—Vincristine—muscle cancer	0.00119	0.00132	CcSEcCtD
Esomeprazole—Vomiting—Dactinomycin—muscle cancer	0.00118	0.00131	CcSEcCtD
Esomeprazole—Agranulocytosis—Methotrexate—muscle cancer	0.00118	0.0013	CcSEcCtD
Esomeprazole—Rash—Dactinomycin—muscle cancer	0.00117	0.0013	CcSEcCtD
Esomeprazole—Decreased appetite—Etoposide—muscle cancer	0.00117	0.00129	CcSEcCtD
Esomeprazole—Pancytopenia—Doxorubicin—muscle cancer	0.00116	0.00129	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Etoposide—muscle cancer	0.00116	0.00129	CcSEcCtD
Esomeprazole—Fatigue—Etoposide—muscle cancer	0.00116	0.00128	CcSEcCtD
Esomeprazole—Pain—Etoposide—muscle cancer	0.00115	0.00127	CcSEcCtD
Esomeprazole—Constipation—Etoposide—muscle cancer	0.00115	0.00127	CcSEcCtD
Esomeprazole—Dysuria—Doxorubicin—muscle cancer	0.00115	0.00127	CcSEcCtD
Esomeprazole—Neutropenia—Doxorubicin—muscle cancer	0.00115	0.00127	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00114	0.00126	CcSEcCtD
Esomeprazole—Diarrhoea—Vincristine—muscle cancer	0.00114	0.00126	CcSEcCtD
Esomeprazole—Hepatitis—Methotrexate—muscle cancer	0.00113	0.00126	CcSEcCtD
Esomeprazole—Pollakiuria—Doxorubicin—muscle cancer	0.00113	0.00125	CcSEcCtD
Esomeprazole—Pharyngitis—Methotrexate—muscle cancer	0.00113	0.00125	CcSEcCtD
Esomeprazole—Urinary tract disorder—Methotrexate—muscle cancer	0.00112	0.00124	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00112	0.00124	CcSEcCtD
Esomeprazole—Weight increased—Doxorubicin—muscle cancer	0.00112	0.00124	CcSEcCtD
Esomeprazole—Urethral disorder—Methotrexate—muscle cancer	0.00111	0.00123	CcSEcCtD
Esomeprazole—Weight decreased—Doxorubicin—muscle cancer	0.00111	0.00123	CcSEcCtD
Esomeprazole—Feeling abnormal—Etoposide—muscle cancer	0.00111	0.00123	CcSEcCtD
Esomeprazole—Nausea—Dactinomycin—muscle cancer	0.0011	0.00122	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Etoposide—muscle cancer	0.0011	0.00122	CcSEcCtD
Esomeprazole—Dizziness—Vincristine—muscle cancer	0.0011	0.00122	CcSEcCtD
Esomeprazole—Infestation NOS—Doxorubicin—muscle cancer	0.00109	0.00121	CcSEcCtD
Esomeprazole—Infestation—Doxorubicin—muscle cancer	0.00109	0.00121	CcSEcCtD
Esomeprazole—Visual impairment—Methotrexate—muscle cancer	0.00109	0.00121	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00108	0.0012	CcSEcCtD
Esomeprazole—Renal failure—Doxorubicin—muscle cancer	0.00107	0.00119	CcSEcCtD
Esomeprazole—Erythema multiforme—Methotrexate—muscle cancer	0.00107	0.00119	CcSEcCtD
Esomeprazole—Urticaria—Etoposide—muscle cancer	0.00107	0.00118	CcSEcCtD
Esomeprazole—Stomatitis—Doxorubicin—muscle cancer	0.00107	0.00118	CcSEcCtD
Esomeprazole—Jaundice—Doxorubicin—muscle cancer	0.00107	0.00118	CcSEcCtD
Esomeprazole—Abdominal pain—Etoposide—muscle cancer	0.00106	0.00118	CcSEcCtD
Esomeprazole—Body temperature increased—Etoposide—muscle cancer	0.00106	0.00118	CcSEcCtD
Esomeprazole—Urinary tract infection—Doxorubicin—muscle cancer	0.00106	0.00118	CcSEcCtD
Esomeprazole—Conjunctivitis—Doxorubicin—muscle cancer	0.00106	0.00118	CcSEcCtD
Esomeprazole—Eye disorder—Methotrexate—muscle cancer	0.00106	0.00117	CcSEcCtD
Esomeprazole—Tinnitus—Methotrexate—muscle cancer	0.00106	0.00117	CcSEcCtD
Esomeprazole—Vomiting—Vincristine—muscle cancer	0.00106	0.00117	CcSEcCtD
Esomeprazole—Rash—Vincristine—muscle cancer	0.00105	0.00116	CcSEcCtD
Esomeprazole—Dermatitis—Vincristine—muscle cancer	0.00105	0.00116	CcSEcCtD
Esomeprazole—Haematuria—Doxorubicin—muscle cancer	0.00104	0.00115	CcSEcCtD
Esomeprazole—Headache—Vincristine—muscle cancer	0.00104	0.00115	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00103	0.00114	CcSEcCtD
Esomeprazole—Epistaxis—Doxorubicin—muscle cancer	0.00103	0.00114	CcSEcCtD
Esomeprazole—Sinusitis—Doxorubicin—muscle cancer	0.00103	0.00114	CcSEcCtD
Esomeprazole—Immune system disorder—Methotrexate—muscle cancer	0.00102	0.00113	CcSEcCtD
Esomeprazole—Mediastinal disorder—Methotrexate—muscle cancer	0.00102	0.00113	CcSEcCtD
Esomeprazole—Agranulocytosis—Doxorubicin—muscle cancer	0.00102	0.00113	CcSEcCtD
Esomeprazole—Chills—Methotrexate—muscle cancer	0.00102	0.00113	CcSEcCtD
Esomeprazole—Alopecia—Methotrexate—muscle cancer	0.001	0.00111	CcSEcCtD
Esomeprazole—Bradycardia—Doxorubicin—muscle cancer	0.000999	0.00111	CcSEcCtD
Esomeprazole—Mental disorder—Methotrexate—muscle cancer	0.000993	0.0011	CcSEcCtD
Esomeprazole—Hypersensitivity—Etoposide—muscle cancer	0.000991	0.0011	CcSEcCtD
Esomeprazole—Malnutrition—Methotrexate—muscle cancer	0.000987	0.00109	CcSEcCtD
Esomeprazole—Nausea—Vincristine—muscle cancer	0.000986	0.00109	CcSEcCtD
Esomeprazole—Rhinitis—Doxorubicin—muscle cancer	0.000984	0.00109	CcSEcCtD
Esomeprazole—Hepatitis—Doxorubicin—muscle cancer	0.000982	0.00109	CcSEcCtD
Esomeprazole—Hypoaesthesia—Doxorubicin—muscle cancer	0.000977	0.00108	CcSEcCtD
Esomeprazole—Pharyngitis—Doxorubicin—muscle cancer	0.000974	0.00108	CcSEcCtD
Esomeprazole—Urinary tract disorder—Doxorubicin—muscle cancer	0.000969	0.00107	CcSEcCtD
Esomeprazole—Oedema peripheral—Doxorubicin—muscle cancer	0.000967	0.00107	CcSEcCtD
Esomeprazole—Dysgeusia—Methotrexate—muscle cancer	0.000966	0.00107	CcSEcCtD
Esomeprazole—Asthenia—Etoposide—muscle cancer	0.000965	0.00107	CcSEcCtD
Esomeprazole—Connective tissue disorder—Doxorubicin—muscle cancer	0.000965	0.00107	CcSEcCtD
Esomeprazole—Urethral disorder—Doxorubicin—muscle cancer	0.000962	0.00107	CcSEcCtD
Esomeprazole—Back pain—Methotrexate—muscle cancer	0.000955	0.00106	CcSEcCtD
Esomeprazole—Pruritus—Etoposide—muscle cancer	0.000951	0.00105	CcSEcCtD
Esomeprazole—Visual impairment—Doxorubicin—muscle cancer	0.000946	0.00105	CcSEcCtD
Esomeprazole—Vision blurred—Methotrexate—muscle cancer	0.00093	0.00103	CcSEcCtD
Esomeprazole—Erythema multiforme—Doxorubicin—muscle cancer	0.000928	0.00103	CcSEcCtD
Esomeprazole—Diarrhoea—Etoposide—muscle cancer	0.00092	0.00102	CcSEcCtD
Esomeprazole—Eye disorder—Doxorubicin—muscle cancer	0.000917	0.00102	CcSEcCtD
Esomeprazole—Ill-defined disorder—Methotrexate—muscle cancer	0.000916	0.00101	CcSEcCtD
Esomeprazole—Tinnitus—Doxorubicin—muscle cancer	0.000915	0.00101	CcSEcCtD
Esomeprazole—Anaemia—Methotrexate—muscle cancer	0.000912	0.00101	CcSEcCtD
Esomeprazole—Flushing—Doxorubicin—muscle cancer	0.000911	0.00101	CcSEcCtD
Esomeprazole—Malaise—Methotrexate—muscle cancer	0.00089	0.000985	CcSEcCtD
Esomeprazole—Dizziness—Etoposide—muscle cancer	0.000889	0.000984	CcSEcCtD
Esomeprazole—Immune system disorder—Doxorubicin—muscle cancer	0.000887	0.000982	CcSEcCtD
Esomeprazole—Vertigo—Methotrexate—muscle cancer	0.000887	0.000982	CcSEcCtD
Esomeprazole—Mediastinal disorder—Doxorubicin—muscle cancer	0.000885	0.000979	CcSEcCtD
Esomeprazole—Leukopenia—Methotrexate—muscle cancer	0.000883	0.000978	CcSEcCtD
Esomeprazole—Chills—Doxorubicin—muscle cancer	0.000881	0.000975	CcSEcCtD
Esomeprazole—Alopecia—Doxorubicin—muscle cancer	0.000867	0.00096	CcSEcCtD
Esomeprazole—Cough—Methotrexate—muscle cancer	0.000861	0.000953	CcSEcCtD
Esomeprazole—Mental disorder—Doxorubicin—muscle cancer	0.00086	0.000952	CcSEcCtD
Esomeprazole—Vomiting—Etoposide—muscle cancer	0.000855	0.000946	CcSEcCtD
Esomeprazole—Malnutrition—Doxorubicin—muscle cancer	0.000854	0.000946	CcSEcCtD
Esomeprazole—Rash—Etoposide—muscle cancer	0.000848	0.000939	CcSEcCtD
Esomeprazole—Dermatitis—Etoposide—muscle cancer	0.000847	0.000938	CcSEcCtD
Esomeprazole—Headache—Etoposide—muscle cancer	0.000842	0.000933	CcSEcCtD
Esomeprazole—Flatulence—Doxorubicin—muscle cancer	0.000842	0.000932	CcSEcCtD
Esomeprazole—Chest pain—Methotrexate—muscle cancer	0.00084	0.00093	CcSEcCtD
Esomeprazole—Myalgia—Methotrexate—muscle cancer	0.00084	0.00093	CcSEcCtD
Esomeprazole—Arthralgia—Methotrexate—muscle cancer	0.00084	0.00093	CcSEcCtD
Esomeprazole—Tension—Doxorubicin—muscle cancer	0.000838	0.000928	CcSEcCtD
Esomeprazole—Dysgeusia—Doxorubicin—muscle cancer	0.000837	0.000926	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000834	0.000924	CcSEcCtD
Esomeprazole—Discomfort—Methotrexate—muscle cancer	0.00083	0.000919	CcSEcCtD
Esomeprazole—Nervousness—Doxorubicin—muscle cancer	0.00083	0.000919	CcSEcCtD
Esomeprazole—Back pain—Doxorubicin—muscle cancer	0.000827	0.000915	CcSEcCtD
Esomeprazole—Muscle spasms—Doxorubicin—muscle cancer	0.000822	0.00091	CcSEcCtD
Esomeprazole—Confusional state—Methotrexate—muscle cancer	0.000812	0.000899	CcSEcCtD
Esomeprazole—Anaphylactic shock—Methotrexate—muscle cancer	0.000805	0.000892	CcSEcCtD
Esomeprazole—Vision blurred—Doxorubicin—muscle cancer	0.000805	0.000892	CcSEcCtD
Esomeprazole—Infection—Methotrexate—muscle cancer	0.0008	0.000886	CcSEcCtD
Esomeprazole—Nausea—Etoposide—muscle cancer	0.000799	0.000884	CcSEcCtD
Esomeprazole—Ill-defined disorder—Doxorubicin—muscle cancer	0.000793	0.000878	CcSEcCtD
Esomeprazole—Nervous system disorder—Methotrexate—muscle cancer	0.00079	0.000874	CcSEcCtD
Esomeprazole—Anaemia—Doxorubicin—muscle cancer	0.00079	0.000874	CcSEcCtD
Esomeprazole—Thrombocytopenia—Methotrexate—muscle cancer	0.000789	0.000873	CcSEcCtD
Esomeprazole—Agitation—Doxorubicin—muscle cancer	0.000785	0.000869	CcSEcCtD
Esomeprazole—Skin disorder—Methotrexate—muscle cancer	0.000782	0.000866	CcSEcCtD
Esomeprazole—Hyperhidrosis—Methotrexate—muscle cancer	0.000779	0.000862	CcSEcCtD
Esomeprazole—Malaise—Doxorubicin—muscle cancer	0.000771	0.000853	CcSEcCtD
Esomeprazole—Vertigo—Doxorubicin—muscle cancer	0.000768	0.00085	CcSEcCtD
Esomeprazole—Anorexia—Methotrexate—muscle cancer	0.000768	0.00085	CcSEcCtD
Esomeprazole—Leukopenia—Doxorubicin—muscle cancer	0.000765	0.000847	CcSEcCtD
Esomeprazole—Palpitations—Doxorubicin—muscle cancer	0.000755	0.000836	CcSEcCtD
Esomeprazole—Cough—Doxorubicin—muscle cancer	0.000746	0.000826	CcSEcCtD
Esomeprazole—Hypertension—Doxorubicin—muscle cancer	0.000738	0.000817	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000734	0.000812	CcSEcCtD
Esomeprazole—Insomnia—Methotrexate—muscle cancer	0.000728	0.000806	CcSEcCtD
Esomeprazole—Chest pain—Doxorubicin—muscle cancer	0.000727	0.000805	CcSEcCtD
Esomeprazole—Myalgia—Doxorubicin—muscle cancer	0.000727	0.000805	CcSEcCtD
Esomeprazole—Arthralgia—Doxorubicin—muscle cancer	0.000727	0.000805	CcSEcCtD
Esomeprazole—Anxiety—Doxorubicin—muscle cancer	0.000725	0.000803	CcSEcCtD
Esomeprazole—Paraesthesia—Methotrexate—muscle cancer	0.000723	0.000801	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000722	0.0008	CcSEcCtD
Esomeprazole—Discomfort—Doxorubicin—muscle cancer	0.000719	0.000796	CcSEcCtD
Esomeprazole—Dyspnoea—Methotrexate—muscle cancer	0.000718	0.000795	CcSEcCtD
Esomeprazole—Somnolence—Methotrexate—muscle cancer	0.000716	0.000793	CcSEcCtD
Esomeprazole—Dry mouth—Doxorubicin—muscle cancer	0.000711	0.000788	CcSEcCtD
Esomeprazole—Dyspepsia—Methotrexate—muscle cancer	0.000709	0.000785	CcSEcCtD
Esomeprazole—Confusional state—Doxorubicin—muscle cancer	0.000703	0.000778	CcSEcCtD
Esomeprazole—Decreased appetite—Methotrexate—muscle cancer	0.0007	0.000775	CcSEcCtD
Esomeprazole—Anaphylactic shock—Doxorubicin—muscle cancer	0.000697	0.000772	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000695	0.00077	CcSEcCtD
Esomeprazole—Fatigue—Methotrexate—muscle cancer	0.000694	0.000769	CcSEcCtD
Esomeprazole—Infection—Doxorubicin—muscle cancer	0.000693	0.000767	CcSEcCtD
Esomeprazole—Pain—Methotrexate—muscle cancer	0.000689	0.000762	CcSEcCtD
Esomeprazole—Shock—Doxorubicin—muscle cancer	0.000686	0.00076	CcSEcCtD
Esomeprazole—Nervous system disorder—Doxorubicin—muscle cancer	0.000684	0.000757	CcSEcCtD
Esomeprazole—Thrombocytopenia—Doxorubicin—muscle cancer	0.000683	0.000756	CcSEcCtD
Esomeprazole—Tachycardia—Doxorubicin—muscle cancer	0.000681	0.000754	CcSEcCtD
Esomeprazole—Skin disorder—Doxorubicin—muscle cancer	0.000677	0.00075	CcSEcCtD
Esomeprazole—Hyperhidrosis—Doxorubicin—muscle cancer	0.000674	0.000746	CcSEcCtD
Esomeprazole—Anorexia—Doxorubicin—muscle cancer	0.000665	0.000736	CcSEcCtD
Esomeprazole—Feeling abnormal—Methotrexate—muscle cancer	0.000664	0.000735	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Methotrexate—muscle cancer	0.000659	0.000729	CcSEcCtD
Esomeprazole—Urticaria—Methotrexate—muscle cancer	0.00064	0.000708	CcSEcCtD
Esomeprazole—Abdominal pain—Methotrexate—muscle cancer	0.000637	0.000705	CcSEcCtD
Esomeprazole—Body temperature increased—Methotrexate—muscle cancer	0.000637	0.000705	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000635	0.000703	CcSEcCtD
Esomeprazole—Insomnia—Doxorubicin—muscle cancer	0.000631	0.000698	CcSEcCtD
Esomeprazole—Paraesthesia—Doxorubicin—muscle cancer	0.000626	0.000693	CcSEcCtD
Esomeprazole—Dyspnoea—Doxorubicin—muscle cancer	0.000622	0.000688	CcSEcCtD
Esomeprazole—Somnolence—Doxorubicin—muscle cancer	0.00062	0.000686	CcSEcCtD
Esomeprazole—Dyspepsia—Doxorubicin—muscle cancer	0.000614	0.00068	CcSEcCtD
Esomeprazole—Decreased appetite—Doxorubicin—muscle cancer	0.000606	0.000671	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000602	0.000667	CcSEcCtD
Esomeprazole—Fatigue—Doxorubicin—muscle cancer	0.000601	0.000666	CcSEcCtD
Esomeprazole—Pain—Doxorubicin—muscle cancer	0.000596	0.00066	CcSEcCtD
Esomeprazole—Constipation—Doxorubicin—muscle cancer	0.000596	0.00066	CcSEcCtD
Esomeprazole—Hypersensitivity—Methotrexate—muscle cancer	0.000593	0.000657	CcSEcCtD
Esomeprazole—Asthenia—Methotrexate—muscle cancer	0.000578	0.00064	CcSEcCtD
Esomeprazole—Feeling abnormal—Doxorubicin—muscle cancer	0.000575	0.000636	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00057	0.000631	CcSEcCtD
Esomeprazole—Pruritus—Methotrexate—muscle cancer	0.00057	0.000631	CcSEcCtD
Esomeprazole—Urticaria—Doxorubicin—muscle cancer	0.000554	0.000613	CcSEcCtD
Esomeprazole—Abdominal pain—Doxorubicin—muscle cancer	0.000551	0.00061	CcSEcCtD
Esomeprazole—Body temperature increased—Doxorubicin—muscle cancer	0.000551	0.00061	CcSEcCtD
Esomeprazole—Diarrhoea—Methotrexate—muscle cancer	0.000551	0.00061	CcSEcCtD
Esomeprazole—Dizziness—Methotrexate—muscle cancer	0.000533	0.00059	CcSEcCtD
Esomeprazole—Hypersensitivity—Doxorubicin—muscle cancer	0.000514	0.000569	CcSEcCtD
Esomeprazole—Vomiting—Methotrexate—muscle cancer	0.000512	0.000567	CcSEcCtD
Esomeprazole—Rash—Methotrexate—muscle cancer	0.000508	0.000562	CcSEcCtD
Esomeprazole—Dermatitis—Methotrexate—muscle cancer	0.000507	0.000562	CcSEcCtD
Esomeprazole—Headache—Methotrexate—muscle cancer	0.000505	0.000559	CcSEcCtD
Esomeprazole—Asthenia—Doxorubicin—muscle cancer	0.0005	0.000554	CcSEcCtD
Esomeprazole—Pruritus—Doxorubicin—muscle cancer	0.000493	0.000546	CcSEcCtD
Esomeprazole—Nausea—Methotrexate—muscle cancer	0.000478	0.00053	CcSEcCtD
Esomeprazole—Diarrhoea—Doxorubicin—muscle cancer	0.000477	0.000528	CcSEcCtD
Esomeprazole—Dizziness—Doxorubicin—muscle cancer	0.000461	0.000511	CcSEcCtD
Esomeprazole—Vomiting—Doxorubicin—muscle cancer	0.000443	0.000491	CcSEcCtD
Esomeprazole—Rash—Doxorubicin—muscle cancer	0.00044	0.000487	CcSEcCtD
Esomeprazole—Dermatitis—Doxorubicin—muscle cancer	0.000439	0.000486	CcSEcCtD
Esomeprazole—Headache—Doxorubicin—muscle cancer	0.000437	0.000484	CcSEcCtD
Esomeprazole—Nausea—Doxorubicin—muscle cancer	0.000414	0.000459	CcSEcCtD
